ReviewFrontiers in immunology2026
Canonical and emerging regulatory mechanisms of tissue remodeling: shared principles across organs and therapeutic opportunities.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tissue remodeling refers to the structural and functional alterations an organ undergoes in response to changing environmental conditions. This process is precisely regulated by complex signaling networks. While these networks are essential for physiological repair, their dysregulation can lead to pathological conditions. Traditionally, this process is driven by a core set of molecular pathways, including the TGF-β superfamily, growth factors, and the MMPs/TIMPs system. These pathways primarily influence extracellular matrix turnover and fibroblast activation. The resulting inflammatory microenvironment is further modulated by changes in the Th1/Th2 balance and macrophage polarization. Recent studies, however, have highlighted the critical role of emerging regulatory networks. Mechanical signals are now understood to be transduced through the integrin-YAP/TAZ axis. Additionally, metabolic reprogramming, mediated by the glycolysis-HIF-mTOR axis, supplies the necessary energy for cell activation. Non-coding RNAs further refine these processes through multi-level regulation. This review synthesizes both canonical and emerging mechanisms. Our aim is to uncover the shared principles underlying pathological remodeling in different organs, providing a theoretical foundation for the development of precision intervention strategies across diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.